Video

Finding CDMO Capacity In Radiopharmaceutical Drug Development

Source: Outsourced Pharma

In this segment of the Outsourced Pharma Live virtual event A New Age For Small Molecule Development, Conrad Wüllerm MSc, Director of Strategy & Operations, ARTBIO discusses challenges unique to the development and manufacturing of radiopharmaceuticals, a growing area of interest and activity for large and small biopharmaceutical companies. Timelines are particularly important for radiopharmaceutical manufacturing, due to short product half-lives, explains Wüllerm.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)